vs
Side-by-side financial comparison of ACHIEVE LIFE SCIENCES, INC. (ACHV) and NEOGEN CORP (NEOG). Click either name above to swap in a different company.
Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19, including ledipasvir/sofosbuvir and sofosbuvir. Gilead is a member of the Nasdaq-100 and the S&P 100.
Neogen Corporation is an international food safety company that provides test kits and relevant products to detect dangerous substances in food. The company was founded in 1982 and is based in Lansing, Michigan. The company serves a wide range of countries including Canada, United States, the United Kingdom, parts of Europe, Mexico and Brazil, India, and China, among others. The company operates a product line of over 100 drug detection test kits worldwide for the detection of about 300 abuse...
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $224.7M | ||
| Q3 25 | — | $209.2M | ||
| Q2 25 | — | $225.4M | ||
| Q1 25 | — | $221.0M | ||
| Q4 24 | — | $231.3M | ||
| Q3 24 | — | $217.0M | ||
| Q2 24 | — | $236.8M | ||
| Q1 24 | — | $228.8M |
| Q4 25 | — | $-15.9M | ||
| Q3 25 | — | $36.3M | ||
| Q2 25 | — | $-612.3M | ||
| Q1 25 | — | $-10.9M | ||
| Q4 24 | — | $-456.3M | ||
| Q3 24 | — | $-12.6M | ||
| Q2 24 | — | $-5.4M | ||
| Q1 24 | — | $-2.0M |
| Q4 25 | — | 47.5% | ||
| Q3 25 | — | 45.4% | ||
| Q2 25 | — | 41.2% | ||
| Q1 25 | — | 49.9% | ||
| Q4 24 | — | 49.0% | ||
| Q3 24 | — | 48.4% | ||
| Q2 24 | — | 47.9% | ||
| Q1 24 | — | 51.1% |
| Q4 25 | — | -2.4% | ||
| Q3 25 | — | -7.7% | ||
| Q2 25 | — | -271.1% | ||
| Q1 25 | — | 2.4% | ||
| Q4 24 | — | -197.8% | ||
| Q3 24 | — | 1.0% | ||
| Q2 24 | — | 5.5% | ||
| Q1 24 | — | 5.3% |
| Q4 25 | — | -7.1% | ||
| Q3 25 | — | 17.4% | ||
| Q2 25 | — | -271.6% | ||
| Q1 25 | — | -4.9% | ||
| Q4 24 | — | -197.3% | ||
| Q3 24 | — | -5.8% | ||
| Q2 24 | — | -2.3% | ||
| Q1 24 | — | -0.9% |
| Q4 25 | — | $-0.07 | ||
| Q3 25 | — | $0.17 | ||
| Q2 25 | — | $-2.82 | ||
| Q1 25 | — | $-0.05 | ||
| Q4 24 | — | $-2.10 | ||
| Q3 24 | — | $-0.06 | ||
| Q2 24 | — | $-0.02 | ||
| Q1 24 | — | $-0.01 |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
